Clinical Trials Logo

Clinical Trial Summary

Patients undergoing thyroidectomy will be divided into three groups (30 cm H2O Group I, 40 cm H2O Group II, 50 cmH2O Group III). At the end of the operation patients will be applied peak airway pressure manually according to involved groups.The time until the first hemorrhage is seen in each group or if not seen pressure will be applied for 30 seconds and then will be ended.We will record the blood pressure, spO2, HR, the first ETCO2 after the procedure, postoperative haemorrhage that required surgery, and postoperative hematomas during peak airway pressure increase during the operation in all patients. The 1st hour blood pressure, nausea-vomiting score and pain score (NRS) will be recorded in the postoperative recovery unit.

The primary end point of the study is intraoperative bleeding detected, and the secondary end point is postoperative bleeding.


Clinical Trial Description

Patients will be divided into three groups (https://www.randomizer.org/) by computer assisted randomization method (30 cm H2O in Group I, 40 cm H2O in Group II, 50 cmH2O in Group III peak pressure will be applied). The time until the first hemorrhage is seen in each group or if not seen pressure will be applied for 30 seconds and then will be ended.

Patients will be taken to the operation table and standard monitorization will be performed consisting of ECG, non-invasive blood pressure and peripheral O2 saturation from the back region. Anesthesia was induced with 2 mg / kg propofol (propofol 1% Fresenius, Fresenius Kabi, Germany), 2 mg / kg fentanyl (Talinat 0,5mg / 10ml, AND, Turkey), 0.6 mg / kg rocuronium (Muscuro 50mg / 5ml, Kocak Farma , Turkey) will be provided after the patients were intubated orally. General anesthesia treatment will be provided with 2% Sevoflurane in 40% oxygen-air mixture. All patients will be ventilated in pressure controlled mode; respiratory frequency: 12 / min, FiO2: 40% (oxygen-air mixture), I/E:1/2, PEEP: 7 cmH2O supplying end tidal CO2 value of 32-36 mmHg.

Calculating the ideal weight of the patient, isolated-S (Polifarma, Turkey)2ml/kg/h will be infused. If the systolic arterial pressure (SAB) or heart rate (HR) increases by 20% compared to baseline, IV 50 μg fentanyl will be administered. At the end of the operation, the patient's airway peak pressure will be increased before hemostasis is provided by the same surgeon (S.T.). Positive pressure on the Maquet Flow I device (Maquet Flow I-AGC, Rastatt, USA) will be applied manually(30 cm H2O in Group I, 40 cm H2O in Group II patients and 50 cm H2O in group III patients). The airway peak pressure increase will be maintained and recorded until the surgeon sees the first bleeding point or if not seen for 30 seconds. For all three groups this process will be repeated one more time.

After peak airway pressure is increased, the number of bleeding centers detected, how long time did it take to detect and the size of the bleeding vessel (<2 mm or> 2 mm)will be recorded. We will record the blood pressure, spO2, HR, the first ETCO2 after the procedure, postoperative haemorrhage that required surgery, and postoperative hematomas during peak airway pressure increase during the operation in all patients. The 1st hour blood pressure, nausea-vomiting score and pain score (NRS) will be recorded in the postoperative recovery unit.

The primary end point of the study is intraoperative bleeding detected, and w the secondary end point is postoperative bleeding. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03547648
Study type Interventional
Source Istanbul University
Contact
Status Completed
Phase N/A
Start date June 15, 2018
Completion date November 16, 2018

See also
  Status Clinical Trial Phase
Terminated NCT04614389 - Utility of Contrast-Enhanced Sonography and Shear Wave Elastography N/A
Recruiting NCT03295955 - Comparing Efficacy of Postoperative Oral Antibiotic Use in Trans-Oral Thyroidectomy N/A
Completed NCT04647006 - Comparison of TOETVA and Conventional Thyroidectomy N/A
Not yet recruiting NCT06029946 - B-mode Ultrasound, Sono-Elastography, and Diffusion-weighted Imaging MRI in Thyroid Nodules
Recruiting NCT05025046 - NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules
Terminated NCT01320813 - Trial Comparing Complication Rates Associated With Robot-assisted Thyroidectomy to External Thyroidectomy N/A
Completed NCT00877630 - Minimal Invasiveness of Endoscopic Thyroidectomy N/A
Completed NCT01964508 - microRNA in Thyroid Cancer
Completed NCT06306599 - Ultrasound Operator Influence on Diagnostics With AI for Thyroid Nodules - Clinial Trial N/A
Recruiting NCT04730726 - In Vivo Multispectral Optoacoustic Imaging of Thyroid Nodules N/A
Not yet recruiting NCT03884140 - Clinical Diagnostic Approach for Cases of Thyroid Nodules
Completed NCT04277455 - Effect of Ultrasound Guided Laser Ablation Therapy on Symptomatic Benign Thyroid Nodules N/A
Recruiting NCT02225509 - Clinical Validation of a Molecular Signature to Detect Cancer in Thyroid Nodules With Indeterminate Cytology N/A
Completed NCT00552253 - Levothyroxine Treatment in Thyroid Benign Nodular Goiter N/A
Not yet recruiting NCT03700762 - Application of Ultrasonic Gray-scale Ratio in Differentiating Benign From Malignant Thyroid Nodules.
Enrolling by invitation NCT01757834 - Shear Wave Ultrasound Elastography in Noninvasive Diagnosis of Thyroid Nodules N/A
Completed NCT01292044 - The Role of Elastography in the Diagnosis of Thyroid Nodules N/A
Completed NCT00858104 - Percutaneous Laser Ablation in Benign Thyroid Nodules.Long Term Results Phase 4
Completed NCT00651625 - Reciprocating Medical Devices - a Study of a New Safety Device N/A
Completed NCT05132478 - The Effect of Surgeon Emotional Support on Treatment Choice for Low-risk Thyroid Cancer N/A